This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Heart disease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and geneticpredispositions. While you can’t change your genetic code, having a family history of heart disease does not mean your fate is sealed.
These guidelines emphasize modifiable riskfactors and population-specific considerations, covering a range of cardiovascular conditions, including hypertension, diabetes, atherosclerotic disease, and geneticpredispositions to stroke.
Traditional riskfactors are rare in patients with SCAD, except for hypertension. Patients diagnosed with SCAD have different combinations of riskfactors compared with patients who have atherosclerotic changes in their coronary arteries.
Background:Clinical and geneticpredispositions are significant in predicting atrial fibrillation (AF); however, their role in patients with hypertrophic cardiomyopathy (HCM) remains unclear. Stroke, Volume 56, Issue Suppl_1 , Page ATMP101-ATMP101, February 1, 2025.
Although mediation analysis demonstrated that the association between PGSMDand CVDs in females was partly mediated by baseline body mass index, hypercholesterolemia, hypertension, and smoking, these riskfactors did not explain the higher risk compared with males.
While CAC is typically associated with traditional riskfactors such as age, hypertension, and smoking, paradoxically elevated CAC scores have been observed in male endurance athletes despite their otherwise healthy profiles. Traditional RiskFactors Age was one of the strongest predictors.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content